StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Precision BioSciences's revenue for the twelve months ending Jun 30, 2026 was $45.06M, up 3473.0% year over year. For fiscal 2025 it was $34.26M, down 50.1% from the year before. The highest annual figure on record is $115.53M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$34.26M-50.1%
FY2024Dec 31, 2024$68.70M+41.0%
FY2023Dec 31, 2023$48.73M+94.1%
FY2022Dec 31, 2022$25.10M-78.3%
FY2021Dec 31, 2021$115.53M+375.7%
FY2020Dec 31, 2020$24.29M+9.2%
FY2019Dec 31, 2019$22.24M+104.3%
FY2018Dec 31, 2018$10.88M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$10.84M+37272.4%
Q4 FY2025Dec 31, 2025$34.20M+5261.1%
Q3 FY2025Sep 30, 2025$13.00K-97.7%
Q2 FY2025Jun 30, 2025$18.00K-100.0%
Q1 FY2025Mar 31, 2025$29.00K-99.8%
Q4 FY2024Dec 31, 2024$638.00K-90.9%
Q3 FY2024Sep 30, 2024$576.00K-95.6%
Q2 FY2024Jun 30, 2024$49.90M+152.2%
Q1 FY2024Mar 31, 2024$17.58M+100.3%
Q4 FY2023Dec 31, 2023$7.04M-33.6%
Q3 FY2023Sep 30, 2023$13.12M+78.2%
Q2 FY2023Jun 30, 2023$19.79M+418.0%
Q1 FY2023Mar 31, 2023$8.78M+164.7%
Q4 FY2022Dec 31, 2022$10.60M+67.2%
Q3 FY2022Sep 30, 2022$7.36M-69.4%
Q2 FY2022Jun 30, 2022$3.82M-94.4%
Q1 FY2022Mar 31, 2022$3.32M-79.7%
Q4 FY2021Dec 31, 2021$6.34M-28.3%
Q3 FY2021Sep 30, 2021$24.04M+226.4%
Q2 FY2021Jun 30, 2021$68.81M+6282.7%
Q1 FY2021Mar 31, 2021$16.35M+133.6%
Q4 FY2020Dec 31, 2020$8.85M+35.6%
Q3 FY2020Sep 30, 2020$7.36M+51.3%
Q2 FY2020Jun 30, 2020$1.08M-80.0%
Q1 FY2020Mar 31, 2020$7.00M+28.1%
Q4 FY2019Dec 31, 2019$6.52M+32.0%
Q3 FY2019Sep 30, 2019$4.87M+91.5%
Q2 FY2019Jun 30, 2019$5.39M+187.6%
Q1 FY2019Mar 31, 2019$5.46M+257.5%
Q4 FY2018Dec 31, 2018$4.94M–
Q3 FY2018Sep 30, 2018$2.54M–
Q2 FY2018Jun 30, 2018$1.87M–
Q1 FY2018Mar 31, 2018$1.53M–

More Precision BioSciences figures

See a number that looks wrong?